Real-world experience with Curcumin-QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study.
Henit YanaiNir SalomonAdi LahatBella UngarRami EliakimOfra Kriger-SharabiHilla Reiss-MintzBenjamin KoslowskyAriella Bar-Gil ShitritNatalie Tamir-DegabliIris DotanEran ZittanNitsan MaharshakAyal HirschShomron Ben-HorinUri KopylovPublished in: Alimentary pharmacology & therapeutics (2023)
In this real-world cohort, CurQD effectively induced clinical and biomarker remission in patients with active UC, including the biologics/small molecules experienced patients.
Keyphrases
- ulcerative colitis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- study protocol
- randomized controlled trial
- high glucose
- clinical trial
- patient reported outcomes
- systemic lupus erythematosus
- cross sectional
- oxidative stress
- disease activity
- endothelial cells